C4 Therapeutics, Inc. CCCC
$4.08
+4.62%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $12.17
- Implied Upside
- +198.2%
- Price Target Range
- $6.00 – $30.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-01 | Evercore ISI GroupGavin Clark-Gartner |
Maintains | Outperform | $7 → $12 |
| 2026-02-27 | BarclaysEtzer Darout |
Maintains | Overweight | $5 → $7 |
| 2026-02-23 | Brookline CapitalLeah Rush |
Maintains | Buy | $20 → $30 |
| 2025-12-17 | BarclaysEtzer Darout |
Maintains | Overweight | $10 → $5 |
| 2025-12-02 | TD CowenTyler Van Buren |
Initiates coverage on | Buy | — |
| 2025-09-23 | Wells FargoDerek Archila |
Maintains | Overweight | $5 → $10 |
| 2025-09-23 | BarclaysEtzer Darout |
Maintains | Overweight | $8 → $10 |
| 2025-09-22 | Stephens & Co.Sudan Loganathan |
Reiterates | Overweight | $6 |
| 2025-09-17 | BarclaysEtzer Darout |
Initiates coverage on | Overweight | $8 |
| 2025-09-15 | Stephens & Co.Sudan Loganathan |
Upgrades | Equal-weight → Overweight | $3 → $6 |
| 2025-09-04 | GuggenheimBrad Canino |
Initiates coverage on | Buy | $8 |
| 2024-12-19 | Wells FargoDerek Archila |
Upgrades | Equal-weight → Overweight | $8 → $12 |
| 2024-11-18 | Stephens & Co.Sudan Loganathan |
Initiates coverage on | Equal-weight | $4 |
| 2024-08-06 | BMO CapitalEtzer Darout |
Reiterates | Outperform | $20 |
| 2024-05-09 | Wells FargoDerek Archila |
Maintains | Equal-weight | $7 → $8 |
| 2024-05-09 | StifelBradley Canino |
Maintains | Buy | $13 → $14 |
| 2024-02-26 | Morgan StanleyTerence Flynn |
Maintains | Equal-weight | $1 → $8 |
| 2024-02-23 | StifelBradley Canino |
Reiterates | Buy | $12 → $13 |
| 2024-01-29 | JP MorganEric Joseph |
Upgrades | Underweight → Neutral | $6 |
| 2023-12-13 | StifelBradley Canino |
Upgrades | Hold → Buy | $2 → $12 |
| 2023-11-06 | Morgan StanleyTerence Flynn |
Upgrades | Underweight → Equal-weight | $3 → $1 |
| 2023-11-03 | BMO CapitalEtzer Darout |
Maintains | Outperform | $18 → $16 |
| 2023-11-02 | HC Wainwright & Co.Andrew Fein |
Maintains | Buy | $17 → $7 |
| 2023-10-09 | B of A SecuritiesChi Fong |
Maintains | Neutral | $5 → $2 |
| 2023-08-09 | HC Wainwright & Co.Andrew Fein |
Maintains | Buy | $25 → $17 |
| 2023-05-30 | Evercore ISI GroupGavin Clark-Gartner |
Maintains | Outperform | $20 → $10 |
| 2023-05-12 | Morgan StanleyTerence Flynn |
Maintains | Underweight | $5 → $3 |
| 2023-05-08 | HC Wainwright & Co.Andrew Fein |
Maintains | Buy | $35 → $25 |
| 2023-03-28 | B of A SecuritiesChi Fong |
Maintains | Neutral | $11 → $5 |
| 2023-02-27 | Morgan StanleyTerence Flynn |
Maintains | Underweight | $6 → $5 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $4.08
- Market Cap
- $479.80 million
- 52-Week Range
- $1.69 – $5.17
- Average Volume
- 2.85 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.